Kurma Life Sciences Partners Raises €44M for New Fund
Europe-based Kurma Life Sciences Partners said on Thursday that it has closed €44M for Kurma Biofund II: The Orphan Initiative, a fund focused on rare diseases. Investors included KLS Partners, GlaxoSmithKline, bpifrance (CDC Entreprises), Idinvest Partners and New Enterprise Associates.
20 June 2013•6 mins read
